|Having trouble viewing this email? View it as a Web page.
You are subscribed to CDC’s Vaccine Information Statements (VIS) email subscription service. The Tdap vaccine information statement has recently been updated and is now available.
This VIS contains information about Tdap only; for patients receiving Td, continue using the 1/24/12 Td/Tdap VIS until a VIS dedicated exclusively to Td (currently in development) is available.
Changes to the updated VIS relate primarily to recent changes in ACIP recommendations regarding use of Tdap during pregnancy.
A separate “Provider Information” document is available at the same web address. This is a quick reference, summarizing relevant information from ACIP recommendations, which can be useful when discussing the vaccine with patients.